MX2023004520A - Permeacion mejorada de la piel de un peptido novedoso mediante modificacion estructural, mejora quimica y microagujas. - Google Patents
Permeacion mejorada de la piel de un peptido novedoso mediante modificacion estructural, mejora quimica y microagujas.Info
- Publication number
- MX2023004520A MX2023004520A MX2023004520A MX2023004520A MX2023004520A MX 2023004520 A MX2023004520 A MX 2023004520A MX 2023004520 A MX2023004520 A MX 2023004520A MX 2023004520 A MX2023004520 A MX 2023004520A MX 2023004520 A MX2023004520 A MX 2023004520A
- Authority
- MX
- Mexico
- Prior art keywords
- skin permeation
- microneedles
- peptide
- decapeptide
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000000126 substance Substances 0.000 title abstract 2
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 abstract 2
- 108010055060 Lumixyl Proteins 0.000 abstract 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
- 230000035515 penetration Effects 0.000 abstract 2
- 239000003623 enhancer Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical group CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 abstract 1
- 208000000069 hyperpigmentation Diseases 0.000 abstract 1
- 230000003810 hyperpigmentation Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
La hiperpigmentación es una afección común de la piel con graves consecuencias psicosociales. Se ha descubierto que el decapéptido-12, un péptido recién sintetizado, es más seguro que la hidroquinona para reducir el contenido de melanina, con una eficacia de hasta más del 50 por ciento tras 16 semanas de tratamiento dos veces al día. Sin embargo, el péptido sufre una penetración transcutánea limitada debido a su hidrofilicidad y su gran peso molecular. Por lo tanto, el decapéptido-12 se modificó mediante la adición de una cadena de palmitato en un intento de superar esta limitación. También probamos los efectos de los mejoradores de penetración química y las microagujas para suministrar dos péptidos a través de la piel. Se encontró una permeación mejorada de la piel humana mediante el uso de un modelo de permeación de la piel in vitro. Además, examinamos la retención de péptidos de diferentes formulaciones. Nuestros datos de mostraron que los péptidos palmitoilados en el parche de microagujas fueron los más efectivos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063094242P | 2020-10-20 | 2020-10-20 | |
| PCT/US2021/055692 WO2022087026A1 (en) | 2020-10-20 | 2021-10-19 | Enhanced skin permeation of a novel peptide via structural modification, chemical enhancement, and microneedles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023004520A true MX2023004520A (es) | 2023-05-08 |
Family
ID=81291289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023004520A MX2023004520A (es) | 2020-10-20 | 2021-10-19 | Permeacion mejorada de la piel de un peptido novedoso mediante modificacion estructural, mejora quimica y microagujas. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230391825A1 (es) |
| JP (1) | JP2023546301A (es) |
| KR (1) | KR20230091927A (es) |
| CN (1) | CN116782919A (es) |
| AU (1) | AU2021365817A1 (es) |
| CA (1) | CA3195661A1 (es) |
| CO (1) | CO2023006421A2 (es) |
| DE (1) | DE112021005528T5 (es) |
| GB (1) | GB2616142A (es) |
| MX (1) | MX2023004520A (es) |
| WO (1) | WO2022087026A1 (es) |
| ZA (1) | ZA202305228B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2173370B1 (en) * | 2007-06-27 | 2015-10-21 | The Board of Trustees of the Leland Stanford Junior University | Oligopeptide tyrosinase inhibitors and uses thereof |
| JP2020513031A (ja) * | 2017-03-30 | 2020-04-30 | エスケープ・セラピューティクス・インコーポレイテッドＥｓｃａｐｅ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 表皮ケラチノサイト前駆細胞におけるサーチュイン遺伝子発現のデカペプチド−１２モジュレーション |
| WO2020150718A1 (en) * | 2019-01-19 | 2020-07-23 | Escape Therapeutics, Inc. | Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors |
-
2021
- 2021-10-19 MX MX2023004520A patent/MX2023004520A/es unknown
- 2021-10-19 US US18/249,521 patent/US20230391825A1/en active Pending
- 2021-10-19 JP JP2023548546A patent/JP2023546301A/ja active Pending
- 2021-10-19 KR KR1020237016059A patent/KR20230091927A/ko unknown
- 2021-10-19 AU AU2021365817A patent/AU2021365817A1/en active Pending
- 2021-10-19 GB GB2306758.0A patent/GB2616142A/en active Pending
- 2021-10-19 CN CN202180071564.2A patent/CN116782919A/zh active Pending
- 2021-10-19 CA CA3195661A patent/CA3195661A1/en active Pending
- 2021-10-19 WO PCT/US2021/055692 patent/WO2022087026A1/en active Application Filing
- 2021-10-19 DE DE112021005528.3T patent/DE112021005528T5/de active Pending
-
2023
- 2023-05-11 ZA ZA2023/05228A patent/ZA202305228B/en unknown
- 2023-05-16 CO CONC2023/0006421A patent/CO2023006421A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230091927A (ko) | 2023-06-23 |
| WO2022087026A1 (en) | 2022-04-28 |
| JP2023546301A (ja) | 2023-11-01 |
| AU2021365817A1 (en) | 2023-06-22 |
| CO2023006421A2 (es) | 2023-05-29 |
| GB202306758D0 (en) | 2023-06-21 |
| ZA202305228B (en) | 2024-01-31 |
| DE112021005528T5 (de) | 2023-10-26 |
| CA3195661A1 (en) | 2022-04-28 |
| CN116782919A (zh) | 2023-09-19 |
| US20230391825A1 (en) | 2023-12-07 |
| GB2616142A (en) | 2023-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0313474A (pt) | dispositivo de distribuição transdérmica de vacina tendo microprotuberáncias revestidas | |
| WO2019199861A3 (en) | Hemp extract for treatment of pain in animals | |
| RU2013158448A (ru) | Составы кожного наполнителя, включая антиоксиданты | |
| MXPA03001858A (es) | Metodo para el tratamiento de la disfuncion erectil e incremento en el libido del hombre. | |
| MX2020005217A (es) | Composicion oftalmica y dispositivo de administracion de la misma. | |
| EA021963B1 (ru) | Инъецируемая дерматологическая композиция для лечения морщин | |
| BRPI0407485A (pt) | utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina | |
| RU2007138867A (ru) | Режимы дозирования транс-кломифена | |
| ATE418959T1 (de) | Topische zusammensetzun mit natrium hyaluronat fragmente und einen retinoid | |
| RU2013125042A (ru) | Способ предотвращения или лечения опухоли кожи | |
| BRPI0911650B8 (pt) | peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento | |
| JOP20200031A1 (ar) | طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة | |
| EP1676570A1 (en) | Topical pharmaceutical compositions comprising L-arginine and uses thereof | |
| ZA202305228B (en) | Enhanced skin permeation of a novel peptide via structural modification, chemical enhancement, and microneedles | |
| US20070031367A1 (en) | Composition and method for neck skin firming | |
| Wanner et al. | Muscarinic receptors within the ventromedial hypothalamic nuclei modulate metabolic rate during physical exercise | |
| CN107308028A (zh) | 透皮给药精华液 | |
| US20140348873A1 (en) | Urea-Silicone Gel for Hyperkeratosis Treatment | |
| US20200188647A1 (en) | Non-invasive transportation method | |
| PA8615501A1 (es) | Formulaciones farmaceuticas transdermicas | |
| WO2007103190A3 (en) | Transdermal treatment of tendinop athy using no donor | |
| NZ594154A (en) | Transdermal administration of buprenorphine for preoperative treatment of post operative pain | |
| WO2019010301A8 (en) | Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap) | |
| US10086036B2 (en) | Bleomycin-based compositions and use thereof for treating loose skin and fatty tissue | |
| WO2014201083A3 (en) | Phenoxybenzamine transdermal composition |